BioPacific Conference 2013 Agenda

Theme: Thriving in a Challenging Time 迎接挑战, 蓬勃发展

May 11, 2013, Crown Plaza Hotel, Foster City, CA, USA

8:00 – 9:00 am Registration and Vendor Exhibition
9:00 – 9:05 am Welcome Remarks
Zhonghua Pei, Ph.D., CABS President-Elect, BioPacific Organizing Committee Chair
9:05 – 9:15 am State of the Society
Wentao Zhang, , Ph.D., President of CABS
9:15 – 10:30 am Successful Stories & Case Studies of Innovative New Medicine

Session chairpersons: Charlene Liao, Shichang Miao & Jessica Sun

9:15 – 9:40 am Mark Sliwkowski, Ph.D., Distinguished Staff Scientist, Genentech
“Multiple Approaches to Targeting HER/ErbB Receptors in Solid Tumors”
9:40 – 10.05 am Christopher Kirk, Ph.D., Vice President of Research, Onyx
“Towards optimized utility of proteasome inhibitors with peptide epoxyketones”
10:05 – 10.30 am Charles Hart, Ph.D., Vice President of Biology, Threshold
“Selective Targeting of Hypoxic Cancer Cells with the Hypoxia-Activated Prodrug TH-302: Preclinical and Clinical Studies”
10:30 – 10:55 am Break, Vendor Exhibition & Networking
10:55 – 11:10 am CABS K. Fong Award in Life Sciences

Session chairperson: Wentao Zhang
Award Winners: Peter Hirth, PhD & Jean Cui, PhD

11:10 – 11:30 am Special topic
Session chairperson: Zhonghua Pei

Jing Huang, Ph.D., Director-General of China National Center for Biotechnology Development (CNCBD),Ministry of Science & Technology (MOST) of P.R. China
“Biotechnology Policy and Management in China”

11:30 – 12:40 am Genomics & Personalized Medicine

Session chairpersons: Jiangwen Majeti, Sophie Liu & Janet Xiao

11:30 – 11:55 pm Stephen Quake, Professor, Stanford University; Investigator, Howard Hughes Medical Institute (HHMI)
“Single Cell and Single Molecule Genomics”
11:55 – 12:20 pm Radoje Drmanac, Ph.D., Chief Scientific Officer, Complete Genomics
“Accurate whole genome sequencing as the ultimate genetic test enabling personalized disease prevention and treatment”
11:55 – 12:20 pm Jie Zhou, Ph.D., Partner, Morison-Foerster
“Patent protection for personalized medicine inventions”
12:40 – 1:40 pm Lunch
1:40 – 3:15 pm Drug Discovery & Development, Leveraging China-US Collaboration
1:40 – 2:00 pm Ruiping Dong, Ph.D., Senior VP of R&D of Emerging Market, Merck.
“Multi-national Center R&D in China”
2:00 – 2:20 pm Thomas L. Irving, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
“What Innovative Chinese Companies Need to Know to Obtain Strong U.S. Patent Portfolios”
2:20 – 2:40 pm Richard Soll, Ph.D., SVP, WuXi AppTec
“Accelerating Innovation in a Collaborative Biopharma Ecosystem”
2:40 – 3:05 pm Gold Sponsor Presentations
Jeff Moran, Director of Business Development, QPS LLC
Connie Sun, Ph.D., SVP, Sr. Vice President, Pharmaron
Bin Li, CEO, Health-coming
3:05 – 3:35 pm Break: Vendor Exhibition & Networking
3:35 – 5:00 pm Entrepreneurship & Emerging Market

Session chairpersons: Cheni Kwok, Carrie Wang & Jianlong Lou

3:35 – 3:55 pm Neeraj Kumar, Centre Director (Western Americas), Economic Development Board of Singapore
“Singapore – The Biopolis of Asia”
3:55 – 4:15 pm Jonathan Norris, Managing Director, SVB Capital
“Life Science Venture Overview”
4:15 – 4:30 pm Gold Sponsor Presentations
Chen Chen, Ph.D., CEO, Sundia
Ray Zhang, Director of Business Promotion & Portfolio, Simcere Pharmaceutical, China
4:30 – 5:00 pm Corey Goodman, Ph.D., Partner, VenBio
“Building Successful Biotech Companies in a Challenging Environment”
5:00 – 5:20 pm Dinner Setup
5:20 – 6:30 pm Dinner
6:30 -8:30 pm Panel discussion: The journey of Biotech entrepreneurship, From bench to business.
Moderator: Xiaoli Qin


Jay Tong, M.D., Founder, President  & CEO, AllCells, LLC
Hong Tan, Ph.D., founder & CEO of ET Healthcare, Inc.
Songzhu (Michael) An, MD, Ph.D., founder, StemRD and Curegenix
Chris Yu, Ph.D., AnPac Bio-Medical Science Co., Ltd., founder
Richard Qun Shan, Ph.D., Quintana Biosciences, founder, President and CEO
Shawn Lee, Ph.D., Founder and President, CPC Scientific
YinXiang Wang, Ph.D., CEO & CSO, Zhejinag Beta Pharma, Inc, China
Hua Tu, Ph.D., President and CEO, LakePharma, Inc.

8:30 pm Conference Adjourned